Insider Transactions in Q1 2021 at Eloxx Pharmaceuticals, Inc. (ELOX)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 25
2021
|
Gregory C. Williams CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
15,360
-25.6%
|
$46,080
$3.95 P/Share
|
|
Feb 25
2021
|
Gregory C. Williams CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+45.46%
|
-
|
|
Feb 25
2021
|
Neil S. Belloff COO, GENERAL COUNSEL &CORP SEC |
SELL
Payment of exercise price or tax liability
|
Direct |
7,338
-21.96%
|
$22,014
$3.95 P/Share
|
|
Feb 25
2021
|
Neil S. Belloff COO, GENERAL COUNSEL &CORP SEC |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+42.8%
|
-
|
|
Jan 30
2021
|
Gregory C. Williams CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
643
-6.05%
|
$1,929
$3.44 P/Share
|
|
Jan 30
2021
|
Gregory C. Williams CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,875
+14.99%
|
-
|
|
Jan 30
2021
|
Neil S. Belloff COO, GENERAL COUNSEL &CORP SEC |
SELL
Payment of exercise price or tax liability
|
Direct |
542
-6.05%
|
$1,626
$3.44 P/Share
|
|
Jan 30
2021
|
Neil S. Belloff COO, GENERAL COUNSEL &CORP SEC |
BUY
Exercise of conversion of derivative security
|
Direct |
1,563
+14.86%
|
-
|